Jane Street
NVCR icon

Jane Street’s NovoCure NVCR Stock Holding History

Jane Street’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$514K Sell
33,900
-300
-0.9% -$4.54K ﹤0.01% 7952
2026
Q1 		$373K Buy
+34,200
New +$427K ﹤0.01% 8734
2025
Q3 		– Sell
-25,600
Closed -$456K – 11463
2025
Q2 		$456K Buy
+25,600
New +$446K ﹤0.01% 7102
2025
Q1 		– Sell
-32,700
Closed -$974K – 10252
2024
Q4 		$974K Buy
+32,700
New +$692K ﹤0.01% 5447
2024
Q2 		– Sell
-10,500
Closed -$164K – 9940
2024
Q1 		$164K Sell
10,500
-223,100
-96% -$3.28M ﹤0.01% 8291
2023
Q4 		$3.49M Buy
233,600
+164,500
+238% +$2.2M ﹤0.01% 3387
2023
Q3 		$1.12M Sell
69,100
-327,600
-83% -$9.45M ﹤0.01% 5017
2023
Q2 		$16.5M Buy
396,700
+234,800
+145% +$14.6M 0.01% 1411
2023
Q1 		$9.74M Buy
161,900
+28,600
+21% +$2.29M ﹤0.01% 1673
2022
Q4 		$9.78M Buy
133,300
+48,400
+57% +$3.64M ﹤0.01% 1645
2022
Q3 		$6.45M Buy
84,900
+33,000
+64% +$2.57M ﹤0.01% 2237
2022
Q2 		$3.61M Sell
51,900
-11,500
-18% -$866K ﹤0.01% 3154
2022
Q1 		$5.25M Sell
63,400
-9,800
-13% -$722K ﹤0.01% 2948
2021
Q4 		$5.5M Buy
73,200
+7,800
+12% +$783K ﹤0.01% 2707
2021
Q3 		$7.6M Buy
65,400
+41,200
+170% +$6.23M ﹤0.01% 2168
2021
Q2 		$5.37M Sell
24,200
-7,400
-23% -$1.44M ﹤0.01% 2527
2021
Q1 		$4.18M Sell
31,600
-28,300
-47% -$4.48M ﹤0.01% 2674
2020
Q4 		$10.4M Buy
59,900
+1,700
+3% +$233K 0.01% 1388
2020
Q3 		$6.48M Buy
58,200
+13,200
+29% +$1.06M ﹤0.01% 1594
2020
Q2 		$2.67M Buy
45,000
+39,800
+765% +$2.62M ﹤0.01% 2665
2020
Q1 		$350K Sell
5,200
-200
-4% -$15.8K ﹤0.01% 4035
2019
Q4 		$455K Sell
5,400
-5,100
-49% -$412K ﹤0.01% 3801
2019
Q3 		$785K Buy
+10,500
New +$840K ﹤0.01% 2933

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Jane Street's NVCR Position: Q2 2026 in Review

Jane Street opened a new position in NovoCure (NVCR) in Q2 2026: 81,450 shares worth $1.23M. The stake represents ﹤0.01% of the portfolio and ranks #6096 among its holdings. This is a return to the name: Jane Street previously reported a position in NVCR as recently as Q4 2025.

Jane Street first reported a position in NVCR in Q4 2017 and has held it in 28 quarters since. The position peaked at $21.9M in Q2 2023. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Jane Street held 81,450 shares of NovoCure worth $1.23M as of Q2 2026.
  • NovoCure was a new Jane Street position in Q2 2026.
  • NovoCure made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6096 holding.
  • Jane Street first reported a position in NovoCure in Q4 2017 and has held it in 28 quarters since.
  • Jane Street's NovoCure position peaked at $21.9M in Q2 2023.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.